125 related articles for article (PubMed ID: 29912045)
1. Liver Perfusate Natural Killer Cells From Deceased Brain Donors and Association With Acute Cellular Rejection After Liver Transplantation: A Time-to-Rejection Analysis.
Pagano D; Badami E; Conaldi PG; Seidita A; Tuzzolino F; Barbàra M; di Francesco F; Tropea A; Liotta R; Chiarello G; Luca A; Gruttadauria S
Transplantation; 2019 Feb; 103(2):371-380. PubMed ID: 29912045
[TBL] [Abstract][Full Text] [Related]
2. Impact of T Lymphocytes Isolated from Liver Perfusate of Deceased Brain Donors on Kidney Transplantation: Preliminary Evidence and Future Directions.
Pagano D; Badami E; Zito G; Conaldi PG; Vella I; Buscemi B; Amico G; Busà R; Salis P; Li Petri S; di Francesco F; Calamia S; Bonsignore P; Tropea A; Accardo C; Piazza S; Gruttadauria S
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510901
[TBL] [Abstract][Full Text] [Related]
3. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.
Ohira M; Nishida S; Tryphonopoulos P; Tekin A; Selvaggi G; Moon J; Levi D; Ricordi C; Ishiyama K; Tanaka Y; Ohdan H; Tzakis AG
Cell Transplant; 2012; 21(7):1397-406. PubMed ID: 22469170
[TBL] [Abstract][Full Text] [Related]
4. Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma.
Ohira M; Hotta R; Tanaka Y; Matsuura T; Tekin A; Selvaggi G; Vianna R; Ricordi C; Ruiz P; Nishida S; Tzakis AG; Ohdan H
Cancer Immunol Immunother; 2022 Mar; 71(3):589-599. PubMed ID: 34282496
[TBL] [Abstract][Full Text] [Related]
5. CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation.
Raschzok N; Reutzel-Selke A; Schmuck RB; Morgul MH; Gauger U; Prabowo KA; Tannus LM; Leder A; Struecker B; Boas-Knoop S; Bartels M; Jonas S; Lojewski C; Puhl G; Seehofer D; Bahra M; Pascher A; Pratschke J; Sauer IM
Liver Transpl; 2015 Sep; 21(9):1195-207. PubMed ID: 25950774
[TBL] [Abstract][Full Text] [Related]
6. Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients.
Levitsky J; Goldberg D; Smith AR; Mansfield SA; Gillespie BW; Merion RM; Lok AS; Levy G; Kulik L; Abecassis M; Shaked A
Clin Gastroenterol Hepatol; 2017 Apr; 15(4):584-593.e2. PubMed ID: 27567694
[TBL] [Abstract][Full Text] [Related]
7. Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction.
Shi XL; Mancham S; Hansen BE; de Knegt RJ; de Jonge J; van der Laan LJ; Rivadeneira F; Metselaar HJ; Kwekkeboom J
J Hepatol; 2016 Jun; 64(6):1274-82. PubMed ID: 26941095
[TBL] [Abstract][Full Text] [Related]
8. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
Musat AI; Pigott CM; Ellis TM; Agni RM; Leverson GE; Powell AJ; Richards KR; D'Alessandro AM; Lucey MR
Liver Transpl; 2013 Oct; 19(10):1132-41. PubMed ID: 23873778
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients.
Fernández-Ruiz M; Silva JT; López-Medrano F; Allende LM; San Juan R; Cambra F; Justo I; Paz-Artal E; Jiménez C; Aguado JM
Transpl Infect Dis; 2016 Aug; 18(4):552-65. PubMed ID: 27260953
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity of natural killer cells in allogeneic liver transplantation.
Oertel M; Kohlhaw K; Diepolder HM; Schröder S; Schwarz R; Tannapfel A; Mössner J; Hauss J; Berr F
Transplantation; 2001 Jul; 72(1):116-22. PubMed ID: 11468545
[TBL] [Abstract][Full Text] [Related]
12. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
Sarwal MM; Cecka JM; Millan MT; Salvatierra O
Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
[TBL] [Abstract][Full Text] [Related]
13. Single-Center Experience Using Marginal Liver Grafts in Korea.
Park PJ; Yu YD; Yoon YI; Kim SR; Kim DS
Transplant Proc; 2018 May; 50(4):1147-1152. PubMed ID: 29731083
[TBL] [Abstract][Full Text] [Related]
14. Validating Early Post-Transplant Outcomes Reported for Recipients of Deceased Donor Kidney Transplants.
Potluri VS; Parikh CR; Hall IE; Ficek J; Doshi MD; Butrymowicz I; Weng FL; Schröppel B; Thiessen-Philbrook H; Reese PP
Clin J Am Soc Nephrol; 2016 Feb; 11(2):324-31. PubMed ID: 26668026
[TBL] [Abstract][Full Text] [Related]
15. Donor Age Correlates With Liver-Resident Natural Killer Cell Activity in Adoptive Immunotherapy Using Donor Liver Natural Killer Cells in Liver Transplantation.
Ohira M; Imaoka K; Bekki T; Sato K; Imaoka Y; Nakano R; Yano T; Doskali M; Shimizu S; Chogahara I; Sato S; Nakamura M; Tanaka Y; Ohdan H
Transplant Proc; 2024 Apr; 56(3):667-671. PubMed ID: 38326202
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
17. Perioperative changes of procalcitonin levels in patients undergoing liver transplantation.
Kaido T; Ogawa K; Fujimoto Y; Mori A; Hatano E; Okajima H; Uemoto S
Transpl Infect Dis; 2014 Oct; 16(5):790-6. PubMed ID: 25154523
[TBL] [Abstract][Full Text] [Related]
18. Association Between Duration of Delayed Graft Function, Acute Rejection, and Allograft Outcome After Deceased Donor Kidney Transplantation.
Lim WH; Johnson DW; Teixeira-Pinto A; Wong G
Transplantation; 2019 Feb; 103(2):412-419. PubMed ID: 29762458
[TBL] [Abstract][Full Text] [Related]
19. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
20. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
Moroso V; van der Meer A; Tilanus HW; Kazemier G; van der Laan LJ; Metselaar HJ; Joosten I; Kwekkeboom J
Transpl Int; 2011 Sep; 24(9):932-42. PubMed ID: 21672051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
